SCHEMBL8560750

SCHEMBL8560750

CCCn1c2nc[nH]c2c(=O)n2nc(Cc3ccccc3)nc12

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 13/20 0.52
PDE4B Q07343 13/20 0.52
PDE4C Q08493 13/20 0.52
PDE4D Q08499 13/20 0.52
ADORA2A P29274 11/20 0.52
ADORA2B P29275 11/20 0.52
ADORA3 P0DMS8 5/20 0.51
HPGD P15428 1/20 0.47
ADORA1 P30542 1/20 0.47
BLM P54132 1/20 0.47
PDE3A Q14432 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8563751 0.83 ADORA3 (0.46) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL8560745 0.83 ADORA2A (0.44) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL8560002 0.77 ADORA1 (0.58) ADORA2AADORA2BADORA3ADORA1HSD17B10
SCHEMBL4202952 0.77 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7666660 0.77 ADORA2B (0.54) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7001583 0.76 ADORA2A (0.49) ADORA2AADORA2BADORA3HSD17B10
SCHEMBL7665201 0.74 ADORA2A (0.45) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL8559651 0.72 ADORA2B (0.61) ADORA2AADORA2BADORA3HPGDADORA1
SCHEMBL8562832 0.71 ADORA2B (0.43) ADORA2AADORA2BADORA3HPGDADORA1
SCHEMBL7738361 0.70 PDE4A (0.73) PDE4APDE4BPDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880524-A1 NEW TRIAZOLOPURINES, METHOD OF PREPARING THEM AND THEIR USE AS DRUGS Boehringer Ingelheim Pharma KG (DE) 1998-12-02 EP disclosed
WO-1998003511-A1 NEW TRIAZOLOPURINES, METHOD OF PREPARING THEM AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM PHARMA KG (DE) 1998-01-29 WO disclosed